89 related articles for article (PubMed ID: 20026394)
1. Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children.
Walitza S; Kämpf K; Oli RG; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2010 Mar; 193(1):4-8. PubMed ID: 20026394
[TBL] [Abstract][Full Text] [Related]
2. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
3. Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.
Ponsa I; Ramos-Quiroga JA; Ribasés M; Bosch R; Bielsa A; Ordeig MT; Morell M; Miró R; de Cid R; Estivill X; Casas M; Bayés M; Cormand B; Hervás A
Mutat Res; 2009 Jun; 666(1-2):44-9. PubMed ID: 19457516
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic assessment of methylphenidate treatment in pediatric patients treated for attention deficit hyperactivity disorder.
Tucker JD; Suter W; Petibone DM; Thomas RA; Bailey NL; Zhou Y; Zhao Y; Muniz R; Kumar V
Mutat Res; 2009; 677(1-2):53-8. PubMed ID: 19465145
[TBL] [Abstract][Full Text] [Related]
5. Response to comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
El-Zein RA; Hay MJ; Lopez MS; Bondy ML; Morris DL; Legator MS; Abdel-Rahman SZ
Cancer Lett; 2006 Jan; 231(1):146-8. PubMed ID: 16290920
[No Abstract] [Full Text] [Related]
6. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
7. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
[TBL] [Abstract][Full Text] [Related]
8. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
9. Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial.
Işeri E; Kiliç BG; Senol S; Karabacak NI
Methods Find Exp Clin Pharmacol; 2007; 29(1):47-52. PubMed ID: 17344944
[TBL] [Abstract][Full Text] [Related]
10. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic effects in children treated with methylphenidate.
El-Zein RA; Abdel-Rahman SZ; Hay MJ; Lopez MS; Bondy ML; Morris DL; Legator MS
Cancer Lett; 2005 Dec; 230(2):284-91. PubMed ID: 16297714
[TBL] [Abstract][Full Text] [Related]
12. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate is not clastogenic in cultured human lymphocytes and in the mouse bone-marrow micronucleus test.
Suter W; Martus HJ; Elhajouji A
Mutat Res; 2006 Sep; 607(2):153-9. PubMed ID: 16829163
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial.
Keulers EH; Hendriksen JG; Feron FJ; Wassenberg R; Wuisman-Frerker MG; Jolles J; Vles JS
Eur J Paediatr Neurol; 2007 Jan; 11(1):21-8. PubMed ID: 17169593
[TBL] [Abstract][Full Text] [Related]
15. Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
Preston RJ; Kollins SH; Swanson JM; Greenhill LL; Wigal T; Elliott GR; Vitiello B
Cancer Lett; 2005 Dec; 230(2):292-4. PubMed ID: 16019134
[No Abstract] [Full Text] [Related]
16. Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-specific antibody: application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats.
Dobrovolsky VN; Boctor SY; Twaddle NC; Doerge DR; Bishop ME; Manjanatha MG; Kimoto T; Miura D; Heflich RH; Ferguson SA
Environ Mol Mutagen; 2010 Mar; 51(2):138-45. PubMed ID: 19658152
[TBL] [Abstract][Full Text] [Related]
17. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
Flapper BC; Schoemaker MM
Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
[TBL] [Abstract][Full Text] [Related]
18. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
19. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder.
Ozdag MF; Yorbik O; Ulas UH; Hamamcioglu K; Vural O
Int J Pediatr Otorhinolaryngol; 2004 Oct; 68(10):1267-72. PubMed ID: 15364497
[TBL] [Abstract][Full Text] [Related]
20. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.
Johnson KA; Barry E; Bellgrove MA; Cox M; Kelly SP; Dáibhis A; Daly M; Keavey M; Watchorn A; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Gill M
Neuropsychologia; 2008 Apr; 46(5):1532-41. PubMed ID: 18289615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
